Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Current Assets: 2024

Historic Current Assets for Kura Oncology (KURA) over the last 1 years, with Dec 2024 value amounting to $744.8 million.

  • Kura Oncology's Current Assets rose 34.00% to $620.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $620.7 million, marking a year-over-year increase of 34.00%. This contributed to the annual value of $744.8 million for FY2024, which is N/A change from last year.
  • As of FY2024, Kura Oncology's Current Assets stood at $744.8 million.
  • In the past 5 years, Kura Oncology's Current Assets ranged from a high of $744.8 million in FY2024 and a low of $744.8 million during FY2024.
  • For the 1-year period, Kura Oncology's Current Assets averaged around $744.8 million, with its median value being $744.8 million (2024).